Stay updated on GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial
Sign up to get notified when there's something new on the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page.

Latest updates to the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page
- Check3 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 with removal of a 'Back to Top' element; no substantive changes to core content, pricing, stock, dates, or proper nouns.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check18 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as additional drug information related to HIV treatments. Notably, the total number of study locations has decreased from 181 to 180.SummaryDifference6%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page.